NEW YORK, Jan. 17, 2012 /CNW/ - EMO CAPITAL CORP (OTCBB: EMOE) through its subsidiary Nuvitality is pleased to announce the launch of its marketing initiatives in Australia commencing immediately. As part of Nutvitality's global launch Australia represents a new and emerging market for the company in its quest to become a household name in the almost $800 million dollar diet and wellness industry in Australia.
With the amount of overweight and obese Australians on the rise, experts have gone so far as to call it an epidemic. According to the Medical Journal of Australia obesity rates have more than doubled in the last 20 years. This has caused a scare for many Australian citizens who are now seeking weight loss options, but how bad can the numbers really be?
- 67% of Australian adults are overweight
- 20% of Australian adults are obese
- 24% of Australian children and teens are overweight or obese
Neil Kleinman CEO of NuVitality states "Nuvitality has developed a proprietary distribution mechanism of its products and combined this with its unique multi level marketing strategy has positioned itself for rapid growth. Australia represents a significant untapped market we expect significant immediate growth from."
Emo Capital Corp thru its wholly owned subsidiary NuVitality Labs is a direct marketing corporation specialising in health and wellness categories. www.emocapitalcorp.com
Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend", "dramatically" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Emo Capital's filings with the Securities and Exchange Commission. In addition, such statements could be affected by risks and uncertainties related to the ability of the company to control product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on Emo Capitals's website does not constitute a part of this release.
For further information:
Phone: (888) 374-2961